Laser immunotherapy of canine and feline neoplasia

The major cause of treatment failure in human and veterinary cancer patients is tumor invasion and metastasis. The inability of local therapy (surgery, radiation, photodynamic therapy) to eradicate a metastatic cancer presents a challenge in the therapy of residual or micrometastatic disease. Because of its local therapy limitations, chromophore-enhanced selective photothermal laser treatment has been augmented with a superimposed laser-induced systemic photobiological reaction, laser immunotherapy. Laser immunotherapy is a novel cancer treatment consisting of: (1) a laser in the infrared wavelength range (i.e. 805 nm solid state laser); (2) a photosensitizer of the corresponding absorption peak [i.e. indocyanine green (ICG)]; and (3) an immunoadjuvant [i.e. glycated chitosan gel (GCG)]. The intratumor injection of the photosensitizer (ICG) and immunoadjuvant (GCG) solution is followed by noninvasive laser irradiation. The laser energy causes tumor cell destruction by photothermal interaction to reduce the tumor burden and at the same time exposes tumor antigens. The immunoadjuvant concomitantly stimulates the host to mount a systemic anti-tumor immune response against the remaining cells of the tumor and to induce a long-term, tumor-specific immunity. This study investigates the feasibility of utilizing laser immunotherapy as an adjunctive therapy for the control of feline fibrosarcoma in future.

[1]  J Marcinkiewicz,et al.  Immunoadjuvant properties of chitosan. , 1991, Archivum immunologiae et therapiae experimentalis.

[2]  S. Tonkonogy,et al.  A reverse transcription-polymerase chain reaction technique to detect feline cytokine genes. , 1995, Veterinary immunology and immunopathology.

[3]  W. Tompkins,et al.  Tumor necrosis factor-alpha responses are depressed and interleukin-6 responses unaltered in feline immunodeficiency virus infected cats. , 1995, Veterinary immunology and immunopathology.

[4]  B. Chomel,et al.  Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. , 1993, Journal of the American Veterinary Medical Association.

[5]  H. Murakami,et al.  Stimulation of IgM production in human-human hybridoma HB4C5 cells by chitosan. , 1992, Bioscience, biotechnology, and biochemistry.

[6]  Steven L. Jacques,et al.  Laser Tissue Interaction XIII: Photochemical, Photothermal, and Photomechanical , 1999 .

[7]  S. Withrow.  Soft tissue sarcomas. , 1998, The Veterinary quarterly.

[8]  K. Hynynen,et al.  Hyperthermia in cancer treatment. , 1990, Investigative radiology.

[9]  G. A. Alexander,et al.  Hyperthermia in cancer treatment. , 1986, Pennsylvania medicine.

[10]  S L Jacques,et al.  Laser-tissue interactions. Photochemical, photothermal, and photomechanical. , 1992, The Surgical clinics of North America.

[11]  K. Bartels,et al.  Chromophore-enhanced laser-tumor tissue photothermal interaction using an 808-nm diode laser. , 1995, Cancer letters.

[12]  W. Tompkins,et al.  A Reverse Transcription-Quantitative Competitive Polymerase Chain Reaction (RT-qcPCR) Technique to Measure Cytokine Gene Expression in Domestic Mammals , 1996, Veterinary pathology.

[13]  K. Bartels,et al.  Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. , 1996, Cancer letters.

[14]  W. Tompkins,et al.  Induction of IL-2 and lymphokine activated killer cells in the cat. , 1987, Veterinary immunology and immunopathology.

[15]  I. Azuma,et al.  Stimulation of cytokine production in mice using deacetylated chitin. , 1986, Vaccine.

[16]  M. Hendrick,et al.  Focal necrotizing granulomatous panniculitis associated with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases (1988-1989). , 1991, Journal of the American Veterinary Medical Association.

[17]  K. Bartels,et al.  Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser. , 1995, Cancer letters.

[18]  R. Nordquist,et al.  Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. , 1997, Cancer letters.

[19]  M. Mareel,et al.  Mechanisms of Invasion and Metastasis , 1991 .